Literature DB >> 31766065

PSMA-negative prostate cancer and the continued value of choline-PET/CT.

Ian Alberts1, Christos Sachpekidis1, Viktor Fech1, Axel Rominger1, Ali Afshar-Oromieh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31766065     DOI： 10.1055/a-1044-1855

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN： 0029-5566            Impact factor:   1.379


× No keyword cloud information.
  8 in total

Review 1.  Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics.

Authors:  Virginia Liberini; Riccardo Laudicella; Michele Balma; Daniele G Nicolotti; Ambra Buschiazzo; Serena Grimaldi; Leda Lorenzon; Andrea Bianchi; Simona Peano; Tommaso Vincenzo Bartolotta; Mohsen Farsad; Sergio Baldari; Irene A Burger; Martin W Huellner; Alberto Papaleo; Désirée Deandreis
Journal:  Eur Radiol Exp       Date:  2022-06-15

2.  Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis.

Authors:  Ian Leigh Alberts; Svenja Elizabeth Seide; Clemens Mingels; Karl Peter Bohn; Kuangyu Shi; Helle D Zacho; Axel Rominger; Ali Afshar-Oromieh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-06       Impact factor: 9.236

3.  Response to the letter to the Editor by Professors Francesco Giammarile and Stefano Fanti regarding our article "Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT".

Authors:  Yanna-Marina Chevalme; Lotfi Boudali; Marc Janier; Jean-Noël Talbot
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-08       Impact factor: 9.236

4.  Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET.

Authors:  Sinan Wang; Jun Li; Jun Hua; Yang Su; Denis R Beckford-Vera; Walter Zhao; Mayuri Jayaraman; Tony L Huynh; Ning Zhao; Yung-Hua Wang; Yangjie Huang; Fujun Qin; Sui Shen; Daniel Gioeli; Robert Dreicer; Renuka Sriram; Emily A Egusa; Jonathan Chou; Felix Y Feng; Rahul Aggarwal; Michael J Evans; Youngho Seo; Bin Liu; Robert R Flavell; Jiang He
Journal:  Clin Cancer Res       Date:  2020-12-08       Impact factor: 13.801

5.  Assessment of malignancy and PSMA expression of uncertain bone foci in [18F]PSMA-1007 PET/CT for prostate cancer-a single-centre experience of PET-guided biopsies.

Authors:  Bernd Vollnberg; Ian Alberts; Vera Genitsch; Axel Rominger; Ali Afshar-Oromieh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-28       Impact factor: 10.057

6.  Comparing the clinical performance and cost efficacy of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis.

Authors:  Ian Alberts; Clemens Mingels; Helle D Zacho; Sabine Lanz; Heiko Schöder; Axel Rominger; Marcel Zwahlen; Ali Afshar-Oromieh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-11-13       Impact factor: 10.057

7.  Differences in Distribution and Detection Rate of the [68Ga]Ga-PSMA Ligands PSMA-617, -I&T and -11-Inter-Individual Comparison in Patients with Biochemical Relapse of Prostate Cancer.

Authors:  Falk Gühne; Stefanie Radke; Thomas Winkens; Christian Kühnel; Julia Greiser; Philipp Seifert; Robert Drescher; Martin Freesmeyer
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22

8.  The influence of digital PET/CT on diagnostic certainty and interrater reliability in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer.

Authors:  Ian Alberts; Jan-Niklas Hünermund; Christos Sachpekidis; Clemens Mingels; Viktor Fech; Karl Peter Bohn; Axel Rominger; Ali Afshar-Oromieh
Journal:  Eur Radiol       Date:  2021-04-15       Impact factor: 5.315
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.